$F Cashflow Statement | Understand Stock

$11.71 +$0.13 (1.12%) Live

$F Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income/(loss)
Depreciation and tooling amortization (Note 12 and Note 13)
Held-for-sale impairment charges
Brazil manufacturing exit non-cash charges (excluding accelerated depreciation of $145, $322, and $17) (Note 21)
(Gains)/Losses on Extinguishment of Debt
Other amortization
EV asset impairment/program cancellation asset write-downs (including depreciation of $8,140) (Note 13)
Provision for credit and insurance losses
Pension and other postretirement employee benefits (“OPEB”) expense/(income) (Note 16)
Equity method investment (earnings)/losses and impairments in excess of dividends received (Note 14 and Note 23)
Foreign currency adjustments
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments (Note 5)
(Gains) Losses On Changes In Investments In Affiliates
Stock compensation (Note 6)
Provision for/(Benefit from) deferred income taxes
Decrease/(Increase) in finance receivables (wholesale and other)
Decrease/(Increase) in accounts receivable and other assets
Decrease/(Increase) in inventory
Increase/(Decrease) in accounts payable and accrued and other liabilities
Other
Net cash provided by/(used in) operating activities

Cash flows from investing activities
Capital spending
Acquisitions of finance receivables and operating leases
Collections of finance receivables and operating leases
Proceeds from sale of business
Purchases of marketable securities and other investments
Sales and maturities of marketable securities and other investments
Settlements of derivatives
Capital contributions to equity method investments (Note 23)
Returns of capital from equity method investments (Note 23)
Other
Net cash provided by/(used in) investing activities
Cash flows from financing activities
Cash payments for dividends and dividend equivalents
Purchases of common stock
Net changes in short-term debt
Proceeds from issuance of long-term debt
Payments of long-term debt
Other
Net cash provided by/(used in) financing activities
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase/(decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at end of period (Note 9)
Cash, cash equivalents, and restricted cash at beginning of period (Note 9)

Comments